Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study

Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian). To identify novel genome-wide significant loci for PD in Asian individua...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:JAMA neurology Ročník 77; číslo 6; s. 746
Hlavní autori: Foo, Jia Nee, Chew, Elaine Guo Yan, Chung, Sun Ju, Peng, Rong, Blauwendraat, Cornelis, Nalls, Mike A, Mok, Kin Y, Satake, Wataru, Toda, Tatsushi, Chao, Yinxia, Tan, Louis C S, Tandiono, Moses, Lian, Michelle M, Ng, Ebonne Y, Prakash, Kumar-M, Au, Wing-Lok, Meah, Wee-Yang, Mok, Shi Qi, Annuar, Azlina Ahmad, Chan, Anne Y Y, Chen, Ling, Chen, Yongping, Jeon, Beom S, Jiang, Lulu, Lim, Jia Lun, Lin, Juei-Jueng, Liu, Chunfeng, Mao, Chengjie, Mok, Vincent, Pei, Zhong, Shang, Hui-Fang, Shi, Chang-He, Song, Kyuyoung, Tan, Ai Huey, Wu, Yih-Ru, Xu, Yu-Ming, Xu, Renshi, Yan, Yaping, Yang, Jing, Zhang, BaoRong, Koh, Woon-Puay, Lim, Shen-Yang, Khor, Chiea Chuen, Liu, Jianjun, Tan, Eng-King
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.06.2020
Predmet:
ISSN:2168-6157, 2168-6157
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian). To identify novel genome-wide significant loci for PD in Asian individuals and to compare genetic risk between Asian and European cohorts. Genome-wide association data generated from PD cases and controls in an Asian population (ie, Singapore/Malaysia, Hong Kong, Taiwan, mainland China, and South Korea) were collected from January 1, 2016, to December 31, 2018, as part of an ongoing study. Results were combined with inverse variance meta-analysis, and replication of top loci in European and Japanese samples was performed. Discovery samples of 31 575 individuals passing quality control of 35 994 recruited were used, with a greater than 90% participation rate. A replication cohort of 1 926 361 European-ancestry and 3509 Japanese samples was analyzed. Parkinson disease was diagnosed using UK Parkinson's Disease Society Brain Bank Criteria. Genotypes of common variants, association with disease status, and polygenic risk scores. Of 31 575 samples identified, 6724 PD cases (mean [SD] age, 64.3 [10] years; age at onset, 58.8 [10.6] years; 3472 [53.2%] men) and 24 851 controls (age, 59.4 [11.4] years; 11 030 [45.0%] men) were analyzed in the discovery study. Eleven genome-wide significant loci were identified; 2 of these loci were novel (SV2C and WBSCR17) and 9 were previously found in Europeans. Replication in European-ancestry and Japanese samples showed robust association for SV2C (rs246814; odds ratio, 1.16; 95% CI, 1.11-1.21; P = 1.17 × 10-10 in meta-analysis of discovery and replication samples) but showed potential genetic heterogeneity at WBSCR17 (rs9638616; I2=67.1%; P = 3.40 × 10-3 for hetereogeneity). Polygenic risk score models including variants at these 11 loci were associated with a significant improvement in area under the curve over the model based on 78 European loci alone (63.1% vs 60.2%; P = 6.81 × 10-12). This study identified 2 apparently novel gene loci and found 9 previously identified European loci to be associated with PD in this large, meta-genome-wide association study in a worldwide population of Asian individuals and reports similarities and differences in genetic risk factors between Asian and European individuals in the risk for PD. These findings may lead to improved stratification of Asian patients and controls based on polygenic risk scores. Our findings have potential academic and clinical importance for risk stratification and precision medicine in Asia.
AbstractList Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian).ImportanceLarge-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian).To identify novel genome-wide significant loci for PD in Asian individuals and to compare genetic risk between Asian and European cohorts.ObjectivesTo identify novel genome-wide significant loci for PD in Asian individuals and to compare genetic risk between Asian and European cohorts.Genome-wide association data generated from PD cases and controls in an Asian population (ie, Singapore/Malaysia, Hong Kong, Taiwan, mainland China, and South Korea) were collected from January 1, 2016, to December 31, 2018, as part of an ongoing study. Results were combined with inverse variance meta-analysis, and replication of top loci in European and Japanese samples was performed. Discovery samples of 31 575 individuals passing quality control of 35 994 recruited were used, with a greater than 90% participation rate. A replication cohort of 1 926 361 European-ancestry and 3509 Japanese samples was analyzed. Parkinson disease was diagnosed using UK Parkinson's Disease Society Brain Bank Criteria.Design Setting, and ParticipantsGenome-wide association data generated from PD cases and controls in an Asian population (ie, Singapore/Malaysia, Hong Kong, Taiwan, mainland China, and South Korea) were collected from January 1, 2016, to December 31, 2018, as part of an ongoing study. Results were combined with inverse variance meta-analysis, and replication of top loci in European and Japanese samples was performed. Discovery samples of 31 575 individuals passing quality control of 35 994 recruited were used, with a greater than 90% participation rate. A replication cohort of 1 926 361 European-ancestry and 3509 Japanese samples was analyzed. Parkinson disease was diagnosed using UK Parkinson's Disease Society Brain Bank Criteria.Genotypes of common variants, association with disease status, and polygenic risk scores.Main Outcomes and MeasuresGenotypes of common variants, association with disease status, and polygenic risk scores.Of 31 575 samples identified, 6724 PD cases (mean [SD] age, 64.3 [10] years; age at onset, 58.8 [10.6] years; 3472 [53.2%] men) and 24 851 controls (age, 59.4 [11.4] years; 11 030 [45.0%] men) were analyzed in the discovery study. Eleven genome-wide significant loci were identified; 2 of these loci were novel (SV2C and WBSCR17) and 9 were previously found in Europeans. Replication in European-ancestry and Japanese samples showed robust association for SV2C (rs246814; odds ratio, 1.16; 95% CI, 1.11-1.21; P = 1.17 × 10-10 in meta-analysis of discovery and replication samples) but showed potential genetic heterogeneity at WBSCR17 (rs9638616; I2=67.1%; P = 3.40 × 10-3 for hetereogeneity). Polygenic risk score models including variants at these 11 loci were associated with a significant improvement in area under the curve over the model based on 78 European loci alone (63.1% vs 60.2%; P = 6.81 × 10-12).ResultsOf 31 575 samples identified, 6724 PD cases (mean [SD] age, 64.3 [10] years; age at onset, 58.8 [10.6] years; 3472 [53.2%] men) and 24 851 controls (age, 59.4 [11.4] years; 11 030 [45.0%] men) were analyzed in the discovery study. Eleven genome-wide significant loci were identified; 2 of these loci were novel (SV2C and WBSCR17) and 9 were previously found in Europeans. Replication in European-ancestry and Japanese samples showed robust association for SV2C (rs246814; odds ratio, 1.16; 95% CI, 1.11-1.21; P = 1.17 × 10-10 in meta-analysis of discovery and replication samples) but showed potential genetic heterogeneity at WBSCR17 (rs9638616; I2=67.1%; P = 3.40 × 10-3 for hetereogeneity). Polygenic risk score models including variants at these 11 loci were associated with a significant improvement in area under the curve over the model based on 78 European loci alone (63.1% vs 60.2%; P = 6.81 × 10-12).This study identified 2 apparently novel gene loci and found 9 previously identified European loci to be associated with PD in this large, meta-genome-wide association study in a worldwide population of Asian individuals and reports similarities and differences in genetic risk factors between Asian and European individuals in the risk for PD. These findings may lead to improved stratification of Asian patients and controls based on polygenic risk scores. Our findings have potential academic and clinical importance for risk stratification and precision medicine in Asia.Conclusions and RelevanceThis study identified 2 apparently novel gene loci and found 9 previously identified European loci to be associated with PD in this large, meta-genome-wide association study in a worldwide population of Asian individuals and reports similarities and differences in genetic risk factors between Asian and European individuals in the risk for PD. These findings may lead to improved stratification of Asian patients and controls based on polygenic risk scores. Our findings have potential academic and clinical importance for risk stratification and precision medicine in Asia.
Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there are limited studies in the largest population worldwide (ie, Asian). To identify novel genome-wide significant loci for PD in Asian individuals and to compare genetic risk between Asian and European cohorts. Genome-wide association data generated from PD cases and controls in an Asian population (ie, Singapore/Malaysia, Hong Kong, Taiwan, mainland China, and South Korea) were collected from January 1, 2016, to December 31, 2018, as part of an ongoing study. Results were combined with inverse variance meta-analysis, and replication of top loci in European and Japanese samples was performed. Discovery samples of 31 575 individuals passing quality control of 35 994 recruited were used, with a greater than 90% participation rate. A replication cohort of 1 926 361 European-ancestry and 3509 Japanese samples was analyzed. Parkinson disease was diagnosed using UK Parkinson's Disease Society Brain Bank Criteria. Genotypes of common variants, association with disease status, and polygenic risk scores. Of 31 575 samples identified, 6724 PD cases (mean [SD] age, 64.3 [10] years; age at onset, 58.8 [10.6] years; 3472 [53.2%] men) and 24 851 controls (age, 59.4 [11.4] years; 11 030 [45.0%] men) were analyzed in the discovery study. Eleven genome-wide significant loci were identified; 2 of these loci were novel (SV2C and WBSCR17) and 9 were previously found in Europeans. Replication in European-ancestry and Japanese samples showed robust association for SV2C (rs246814; odds ratio, 1.16; 95% CI, 1.11-1.21; P = 1.17 × 10-10 in meta-analysis of discovery and replication samples) but showed potential genetic heterogeneity at WBSCR17 (rs9638616; I2=67.1%; P = 3.40 × 10-3 for hetereogeneity). Polygenic risk score models including variants at these 11 loci were associated with a significant improvement in area under the curve over the model based on 78 European loci alone (63.1% vs 60.2%; P = 6.81 × 10-12). This study identified 2 apparently novel gene loci and found 9 previously identified European loci to be associated with PD in this large, meta-genome-wide association study in a worldwide population of Asian individuals and reports similarities and differences in genetic risk factors between Asian and European individuals in the risk for PD. These findings may lead to improved stratification of Asian patients and controls based on polygenic risk scores. Our findings have potential academic and clinical importance for risk stratification and precision medicine in Asia.
Author Mao, Chengjie
Lim, Shen-Yang
Chen, Yongping
Liu, Jianjun
Wu, Yih-Ru
Koh, Woon-Puay
Chao, Yinxia
Tandiono, Moses
Foo, Jia Nee
Ng, Ebonne Y
Jiang, Lulu
Mok, Kin Y
Peng, Rong
Chung, Sun Ju
Jeon, Beom S
Mok, Vincent
Xu, Yu-Ming
Liu, Chunfeng
Pei, Zhong
Tan, Ai Huey
Annuar, Azlina Ahmad
Lin, Juei-Jueng
Chew, Elaine Guo Yan
Toda, Tatsushi
Lim, Jia Lun
Xu, Renshi
Prakash, Kumar-M
Khor, Chiea Chuen
Nalls, Mike A
Shang, Hui-Fang
Mok, Shi Qi
Tan, Eng-King
Shi, Chang-He
Satake, Wataru
Tan, Louis C S
Zhang, BaoRong
Blauwendraat, Cornelis
Lian, Michelle M
Chan, Anne Y Y
Meah, Wee-Yang
Au, Wing-Lok
Song, Kyuyoung
Yan, Yaping
Yang, Jing
Chen, Ling
Author_xml – sequence: 1
  givenname: Jia Nee
  surname: Foo
  fullname: Foo, Jia Nee
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 2
  givenname: Elaine Guo Yan
  surname: Chew
  fullname: Chew, Elaine Guo Yan
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 3
  givenname: Sun Ju
  surname: Chung
  fullname: Chung, Sun Ju
  organization: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
– sequence: 4
  givenname: Rong
  surname: Peng
  fullname: Peng, Rong
  organization: Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China
– sequence: 5
  givenname: Cornelis
  surname: Blauwendraat
  fullname: Blauwendraat, Cornelis
  organization: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland
– sequence: 6
  givenname: Mike A
  surname: Nalls
  fullname: Nalls, Mike A
  organization: Data Tecnica International LLC, Glen Echo, Maryland
– sequence: 7
  givenname: Kin Y
  surname: Mok
  fullname: Mok, Kin Y
  organization: Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, United Kingdom
– sequence: 8
  givenname: Wataru
  surname: Satake
  fullname: Satake, Wataru
  organization: Department of Neurology, The University of Tokyo Graduate School of Medicine, Bunkyo, Tokyo, Japan
– sequence: 9
  givenname: Tatsushi
  surname: Toda
  fullname: Toda, Tatsushi
  organization: Department of Neurology, The University of Tokyo Graduate School of Medicine, Bunkyo, Tokyo, Japan
– sequence: 10
  givenname: Yinxia
  surname: Chao
  fullname: Chao, Yinxia
  organization: Duke-National University of Singapore Medical School, Singapore, Singapore
– sequence: 11
  givenname: Louis C S
  surname: Tan
  fullname: Tan, Louis C S
  organization: Department of Neurology, National Neuroscience Institute, Singapore, Singapore
– sequence: 12
  givenname: Moses
  surname: Tandiono
  fullname: Tandiono, Moses
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 13
  givenname: Michelle M
  surname: Lian
  fullname: Lian, Michelle M
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 14
  givenname: Ebonne Y
  surname: Ng
  fullname: Ng, Ebonne Y
  organization: Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, Singapore
– sequence: 15
  givenname: Kumar-M
  surname: Prakash
  fullname: Prakash, Kumar-M
  organization: Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore, Singapore
– sequence: 16
  givenname: Wing-Lok
  surname: Au
  fullname: Au, Wing-Lok
  organization: Department of Neurology, National Neuroscience Institute, Singapore, Singapore
– sequence: 17
  givenname: Wee-Yang
  surname: Meah
  fullname: Meah, Wee-Yang
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 18
  givenname: Shi Qi
  surname: Mok
  fullname: Mok, Shi Qi
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 19
  givenname: Azlina Ahmad
  surname: Annuar
  fullname: Annuar, Azlina Ahmad
  organization: Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
– sequence: 20
  givenname: Anne Y Y
  surname: Chan
  fullname: Chan, Anne Y Y
  organization: Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Prince of Wales Hospital, Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, PR China
– sequence: 21
  givenname: Ling
  surname: Chen
  fullname: Chen, Ling
  organization: Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China
– sequence: 22
  givenname: Yongping
  surname: Chen
  fullname: Chen, Yongping
  organization: Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China
– sequence: 23
  givenname: Beom S
  surname: Jeon
  fullname: Jeon, Beom S
  organization: Department of Neurology, Seoul National University Hospital, Jongno-gu, Seoul, South Korea
– sequence: 24
  givenname: Lulu
  surname: Jiang
  fullname: Jiang, Lulu
  organization: Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China
– sequence: 25
  givenname: Jia Lun
  surname: Lim
  fullname: Lim, Jia Lun
  organization: Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
– sequence: 26
  givenname: Juei-Jueng
  surname: Lin
  fullname: Lin, Juei-Jueng
  organization: Department of Neurology, Chushang Show-Chwan Hospital, Zhushan District, Nantou, Taiwan
– sequence: 27
  givenname: Chunfeng
  surname: Liu
  fullname: Liu, Chunfeng
  organization: Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou, PR China
– sequence: 28
  givenname: Chengjie
  surname: Mao
  fullname: Mao, Chengjie
  organization: Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou, PR China
– sequence: 29
  givenname: Vincent
  surname: Mok
  fullname: Mok, Vincent
  organization: Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, Lui Che Woo Institute of Innovative Medicine, Prince of Wales Hospital, Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, PR China
– sequence: 30
  givenname: Zhong
  surname: Pei
  fullname: Pei, Zhong
  organization: Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China
– sequence: 31
  givenname: Hui-Fang
  surname: Shang
  fullname: Shang, Hui-Fang
  organization: Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China
– sequence: 32
  givenname: Chang-He
  surname: Shi
  fullname: Shi, Chang-He
  organization: Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China
– sequence: 33
  givenname: Kyuyoung
  surname: Song
  fullname: Song, Kyuyoung
  organization: Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, South Korea
– sequence: 34
  givenname: Ai Huey
  surname: Tan
  fullname: Tan, Ai Huey
  organization: Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
– sequence: 35
  givenname: Yih-Ru
  surname: Wu
  fullname: Wu, Yih-Ru
  organization: Department of Neurology, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan
– sequence: 36
  givenname: Yu-Ming
  surname: Xu
  fullname: Xu, Yu-Ming
  organization: Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China
– sequence: 37
  givenname: Renshi
  surname: Xu
  fullname: Xu, Renshi
  organization: Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, Jiangxi, PR China
– sequence: 38
  givenname: Yaping
  surname: Yan
  fullname: Yan, Yaping
  organization: Second Affiliated Hospital, Department of Neurology, Zhejiang University College of Medicine, Hangzhou, Zhejiang Province, PR China
– sequence: 39
  givenname: Jing
  surname: Yang
  fullname: Yang, Jing
  organization: Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China
– sequence: 40
  givenname: BaoRong
  surname: Zhang
  fullname: Zhang, BaoRong
  organization: Second Affiliated Hospital, Department of Neurology, Zhejiang University College of Medicine, Hangzhou, Zhejiang Province, PR China
– sequence: 41
  givenname: Woon-Puay
  surname: Koh
  fullname: Koh, Woon-Puay
  organization: Duke-National University of Singapore Medical School, Singapore, Singapore
– sequence: 42
  givenname: Shen-Yang
  surname: Lim
  fullname: Lim, Shen-Yang
  organization: Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
– sequence: 43
  givenname: Chiea Chuen
  surname: Khor
  fullname: Khor, Chiea Chuen
  organization: Singapore Eye Research Institute, Singapore, Singapore
– sequence: 44
  givenname: Jianjun
  surname: Liu
  fullname: Liu, Jianjun
  organization: Human Genetics, Genome Institute of Singapore, ASTAR, Singapore, Singapore
– sequence: 45
  givenname: Eng-King
  surname: Tan
  fullname: Tan, Eng-King
  organization: Duke-National University of Singapore Medical School, Singapore, Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32310270$$D View this record in MEDLINE/PubMed
BookMark eNpVkNtKw0AQhhdRbK19A5G99CZ1T9kk3tVaa6GgeMDLsMlOYNtmN2YTpG_hI7vQCnVuZob5Zv7hv0Cn1llA6IqSCSWE3q5VrSz0rdtOGGFkQgRLT9CQUZlGksbJ6VE9QGPv1yRESojg4hwNOOOUsIQM0c9Sg-1MZUrVGWexq_Cr8Ru8cqXBlWvxi2o3xvowejAelAdsLJ56o6zHymo8c3WjWuOPdu-h-wb4R83Dqw2E7g5P8QKsqyH6NBoC44PSXvut6_XuEp1VauthfMgj9PE4f589RavnxXI2XUVKkKyLRCmZlIVKEkE1QBYXOpE8jjNNQJVxCgljEjgQQbmUOoY0VkWZJUJLLnRVsBG62d9tWvfVg-_y2vgSttvgq-t9znjGhJSCsYBeH9C-qEHnTWtq1e7yPxfZLxG9efw
CitedBy_id crossref_primary_10_1016_j_lmd_2024_100024
crossref_primary_10_1016_j_tjnut_2025_01_028
crossref_primary_10_1038_s41531_023_00465_5
crossref_primary_10_3389_fncel_2024_1437144
crossref_primary_10_1177_17562864251329099
crossref_primary_10_3389_fneur_2022_764917
crossref_primary_10_1016_j_neuro_2024_06_001
crossref_primary_10_1186_s13024_021_00501_z
crossref_primary_10_1038_s41582_020_0379_6
crossref_primary_10_1073_pnas_2302720120
crossref_primary_10_1186_s40035_024_00437_6
crossref_primary_10_3389_fnagi_2024_1361492
crossref_primary_10_1111_ene_15893
crossref_primary_10_1016_j_neurobiolaging_2021_03_006
crossref_primary_10_1097_WCO_0000000000001391
crossref_primary_10_1038_s12276_023_00952_y
crossref_primary_10_3390_brainsci14060522
crossref_primary_10_1038_s10038_022_01058_5
crossref_primary_10_3390_insects14020168
crossref_primary_10_1016_j_parkreldis_2022_02_016
crossref_primary_10_1038_s41531_022_00410_y
crossref_primary_10_1002_ana_26179
crossref_primary_10_1007_s12035_025_04833_5
crossref_primary_10_1002_mds_29126
crossref_primary_10_3390_jpm11101030
crossref_primary_10_3390_genes12071006
crossref_primary_10_1038_s41531_023_00472_6
crossref_primary_10_1212_WNL_0000000000011464
crossref_primary_10_1016_j_neulet_2023_137426
crossref_primary_10_2174_0109298673289286240322041842
crossref_primary_10_1016_j_neurobiolaging_2021_05_019
crossref_primary_10_1111_ene_15785
crossref_primary_10_1002_advs_202503579
crossref_primary_10_3233_JPD_230455
crossref_primary_10_1101_cshperspect_a041774
crossref_primary_10_3390_biology14010098
crossref_primary_10_3233_JPD_223176
crossref_primary_10_3390_genes13030513
crossref_primary_10_1093_bib_bbad417
crossref_primary_10_3389_fnagi_2022_1094914
crossref_primary_10_1016_j_neurobiolaging_2023_11_001
crossref_primary_10_1038_s41531_025_00933_0
crossref_primary_10_3389_fnagi_2022_1021918
crossref_primary_10_3390_genes12111681
crossref_primary_10_1016_j_neurobiolaging_2021_02_022
crossref_primary_10_1093_brain_awab138
crossref_primary_10_1002_mds_28782
crossref_primary_10_1002_mds_28546
crossref_primary_10_1186_s40246_021_00357_w
crossref_primary_10_3390_cells10051030
crossref_primary_10_1186_s13024_021_00509_5
crossref_primary_10_1038_s10038_025_01335_z
crossref_primary_10_1016_j_prdoa_2025_100382
crossref_primary_10_1212_WNL_0000000000200699
crossref_primary_10_1002_ana_26905
crossref_primary_10_1016_j_neuroscience_2023_10_007
crossref_primary_10_1016_j_parkreldis_2022_06_010
crossref_primary_10_7759_cureus_91510
crossref_primary_10_3233_JPD_230428
crossref_primary_10_3390_genes11111385
crossref_primary_10_1016_j_neuropharm_2025_110555
crossref_primary_10_1038_s43587_024_00760_7
crossref_primary_10_1038_s41531_024_00729_8
crossref_primary_10_1016_j_parkreldis_2021_11_021
crossref_primary_10_1038_s41531_023_00456_6
crossref_primary_10_3390_biom12091212
crossref_primary_10_3389_fnins_2021_629156
crossref_primary_10_1038_s41531_023_00580_3
crossref_primary_10_1038_s41594_024_01423_2
crossref_primary_10_1016_j_parkreldis_2024_107208
crossref_primary_10_1007_s12264_023_01031_y
crossref_primary_10_3389_fnagi_2025_1540830
crossref_primary_10_1038_s41588_023_01584_8
crossref_primary_10_1016_j_ajhg_2025_07_014
crossref_primary_10_3390_genes12121975
crossref_primary_10_1016_j_arr_2024_102381
crossref_primary_10_1016_j_parkreldis_2024_107157
crossref_primary_10_1038_s41531_021_00231_5
crossref_primary_10_1186_s12883_024_03914_7
crossref_primary_10_1016_j_neurobiolaging_2020_12_002
crossref_primary_10_1002_mds_30047
crossref_primary_10_1016_j_arr_2022_101648
crossref_primary_10_1038_s41531_023_00504_1
crossref_primary_10_1186_s13287_021_02326_5
crossref_primary_10_1002_mds_30285
crossref_primary_10_3390_cells14151161
crossref_primary_10_1016_j_jbc_2025_110313
crossref_primary_10_3389_fnagi_2022_888942
crossref_primary_10_1002_ana_26090
crossref_primary_10_3233_JPD_212818
crossref_primary_10_4103_NRR_NRR_D_23_01624
crossref_primary_10_1038_s41598_024_80185_9
crossref_primary_10_1038_s41531_022_00375_y
crossref_primary_10_1212_NXG_0000000000200110
crossref_primary_10_1007_s12035_021_02354_5
crossref_primary_10_1016_j_gene_2022_146515
crossref_primary_10_1093_brain_awad247
crossref_primary_10_1016_j_neurobiolaging_2021_06_011
crossref_primary_10_3389_fnins_2024_1210447
crossref_primary_10_3390_ijms26178549
crossref_primary_10_3390_ijms24076338
crossref_primary_10_1038_s41582_024_01023_0
crossref_primary_10_1002_mds_29043
crossref_primary_10_1002_mds_28197
crossref_primary_10_1016_j_parkreldis_2021_08_005
crossref_primary_10_1016_S1474_4422_23_00283_1
crossref_primary_10_1002_mds_29042
crossref_primary_10_1002_mds_29162
crossref_primary_10_1080_14737159_2024_2427625
crossref_primary_10_3233_JPD_230376
crossref_primary_10_1002_alz_13873
crossref_primary_10_1002_mds_29719
crossref_primary_10_1038_s41531_021_00157_y
crossref_primary_10_3233_JPD_212922
crossref_primary_10_1002_mds_28583
crossref_primary_10_1186_s13059_022_02772_1
crossref_primary_10_1002_mds_28621
crossref_primary_10_1002_mds_29676
crossref_primary_10_1038_s41398_021_01436_1
crossref_primary_10_3390_cells10113184
crossref_primary_10_1016_j_scr_2020_102137
crossref_primary_10_1212_WNL_0000000000207725
crossref_primary_10_3390_life11111239
crossref_primary_10_3233_JPD_230341
crossref_primary_10_1038_s41531_020_00127_w
crossref_primary_10_1038_s41531_024_00698_y
crossref_primary_10_1016_j_parkreldis_2023_105319
crossref_primary_10_1016_j_neurobiolaging_2021_08_009
crossref_primary_10_1093_brain_awaa358
crossref_primary_10_1002_mds_29508
crossref_primary_10_1002_mds_29069
crossref_primary_10_1002_ana_26153
crossref_primary_10_1002_ana_27242
crossref_primary_10_1038_s41531_025_00967_4
crossref_primary_10_1002_mds_29343
crossref_primary_10_1515_medgen_2022_2138
crossref_primary_10_3389_fnmol_2021_797833
crossref_primary_10_1016_j_neurobiolaging_2020_10_019
crossref_primary_10_1093_brain_awae398
crossref_primary_10_1177_1877718X241300298
crossref_primary_10_3390_brainsci13111546
crossref_primary_10_1002_mds_28494
crossref_primary_10_1186_s41231_024_00169_9
crossref_primary_10_3389_fnins_2022_889802
crossref_primary_10_1111_ejn_16311
crossref_primary_10_1016_j_ejphar_2025_177419
crossref_primary_10_1038_s41531_024_00780_5
crossref_primary_10_1002_mds_28761
crossref_primary_10_1016_S1474_4422_24_00378_8
crossref_primary_10_1093_brain_awad214
crossref_primary_10_1007_s12264_021_00749_x
crossref_primary_10_1016_j_namjnl_2025_100036
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1001/jamaneurol.2020.0428
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6157
ExternalDocumentID 32310270
Genre Meta-Analysis
Comparative Study
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
4.4
53G
AAGZG
ABIVO
ABJNI
ACDNT
ACGFS
ACPRK
ADBBV
ADHGD
AENEX
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EMOBN
EX3
H13
NPM
OB2
OBH
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
7X8
ID FETCH-LOGICAL-a409t-4c6266ba7741dee95bd763559d0eac58e7226e3e041366d5e85abc974d634dfb2
IEDL.DBID 7X8
ISICitedReferencesCount 162
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000542138800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2168-6157
IngestDate Wed Oct 01 14:34:59 EDT 2025
Thu Apr 03 07:05:42 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a409t-4c6266ba7741dee95bd763559d0eac58e7226e3e041366d5e85abc974d634dfb2
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 32310270
PQID 2392466422
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2392466422
pubmed_primary_32310270
PublicationCentury 2000
PublicationDate 2020-06-01
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA neurology
PublicationTitleAlternate JAMA Neurol
PublicationYear 2020
References 32572178 - Nat Rev Neurol. 2020 Sep;16(9):461-462
32617903 - Intern Emerg Med. 2020 Aug;15(5):901-905
References_xml – reference: 32572178 - Nat Rev Neurol. 2020 Sep;16(9):461-462
– reference: 32617903 - Intern Emerg Med. 2020 Aug;15(5):901-905
SSID ssj0000800434
Score 2.660245
SecondaryResourceType review_article
Snippet Large-scale genome-wide association studies in the European population have identified 90 risk variants associated with Parkinson disease (PD); however, there...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 746
SubjectTerms Aged
Asian People - genetics
Female
Genetic Predisposition to Disease - genetics
Genome-Wide Association Study
Genotype
Humans
Male
Membrane Glycoproteins - genetics
Middle Aged
N-Acetylgalactosaminyltransferases - genetics
Nerve Tissue Proteins - genetics
Parkinson Disease - genetics
Polypeptide N-acetylgalactosaminyltransferase
Risk Factors
White People - genetics
Title Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study
URI https://www.ncbi.nlm.nih.gov/pubmed/32310270
https://www.proquest.com/docview/2392466422
Volume 77
WOSCitedRecordID wos000542138800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC6mm66eXiRWq0ebCmi2FvYZHchiEk1VfBf-JOdyaaxF0HwklMWws5k5pv55kHIiWOkBDeJ87RdzpA6YzJUPlOeSFpxLEJt7LIJfzAIRqNwWCXciqqscmoTS0Ot8gRz5GccHDmOQuf8YvzKcGsUsqvVCo150nAByqBW-6OgzrEgGmqXxDJveQFEScKvu-fs4KFyaCQyENw5xejhd5xZ-pve6n-_dI2sVEiTdqxqrJM5nW2QpX7FpW-SL9uja6qkHc0NvU-LZ3oH4qIAZSk2RJe9YfTKsjg0zWgHmy4LKjNFu_UKw_rspa36mn1rmu4vzmmH3ugsf9HsKVWazigGxWrGzy3y2Lt-6N6yaj8DkxAVTlg7gWjIiyUgyJbSOhSxwvF2IlQOmHMRaB-wnXa1A47S85TQgZBxAgGM8ty2MjHfJgtZnuldQk3sOaExQmsfQigupO-KwDWeC-jKkaFpkuPpXUeg_0hqgOzy9yL6ue0m2bECi8Z2UEfkInjlvrP3h9P7ZBm1wFaBHZCGgb9fH5LF5GOSFm9HpWLBczDsfwNredie
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+Risk+Loci+for+Parkinson+Disease+in+Asians+and+Comparison+of+Risk+Between+Asians+and+Europeans%3A+A+Genome-Wide+Association+Study&rft.jtitle=JAMA+neurology&rft.au=Foo%2C+Jia+Nee&rft.au=Chew%2C+Elaine+Guo+Yan&rft.au=Chung%2C+Sun+Ju&rft.au=Peng%2C+Rong&rft.date=2020-06-01&rft.issn=2168-6157&rft.eissn=2168-6157&rft.volume=77&rft.issue=6&rft.spage=746&rft_id=info:doi/10.1001%2Fjamaneurol.2020.0428&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-6157&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-6157&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-6157&client=summon